Skip to main content
. 2021 Sep 22;156(12):1111–1118. doi: 10.1001/jamasurg.2021.4527

Table 2. Interventions to Facilitate Maturation or Manage Complications.

Indication Kidney failure (n = 353) CKD (n = 182) All participants with matured study AVF (n = 396)
Before maturation Before maturation After maturation
No. of events Participants, No. (%) No. of events Participants, No. (%) No. of events Participants, No. (%)
Thrombosis 18 18 (5.1) 6 6 (3.3) 73 53 (13.4)
Aneurysm 2 2 (0.6) 0 0 37 33 (8.3)
Bleeding/hematoma 1 1 (0.3) 2 2 (1.1) 27 24 (6.1)
Infection 2 1 (0.3) 1 1 (0.5) 3 3 (0.8)
Arterial inflow stenosis 11 8 (2.3) 5 5 (2.7) 32 23 (5.8)
AVF vein stenosis 119 93 (26.3) 51 41 (22.5) 359 153 (38.6)
Central vein stenosis 25 22 (6.2) 9 9 (4.9) 123 58 (14.6)
Accessory vein branch 25 23 (6.5) 12 12 (6.6) 14 13 (3.3)
Inability to cannulate 17 17 (4.8) 9 8 (4.4) 4 4 (1.0)
Hand ischemia 13 11 (3.1) 7 (6 (3.3) 5 5 (1.3)
Noninfectious fluid collection 3 3 (0.8) 0 0 (0) 4 (3 (0.8)
Total interventions 186a 133 (37.7) 88b 63 (34.6) 477c 188 (47.5)

Abbreviations: AVF, arteriovenous fistula; CKD, chronic kidney disease.

a

Events per intervention, mean (SD), 1.27 (0.54).

b

Events per intervention, mean (SD), 1.16 (0.37).

c

Events per intervention, mean (SD), 43 (0.66).